European Pregnancy and Pediatric HIV Cohort Collaboration (EPPICC) study assessing the safety and efficacy of Kaletra oral solution in children aged 14 days to 2 years with HIV-1 infection in Europe

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Other
• Data sources (types), other:
  Pooled analysis of pseudonymized individual patient clinical and laboratory data from the European Union (EU) cohorts participating in the EPPICC pharmacovigilance program (confirmed to have eligible patients, as of August 2019).; Other EU cohorts within EPPICC who may have eligible patients in the future.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No